Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence ; volume:15 ; number:1 ; day:11 ; month:6 ; year:2022 ; pages:1-30 ; date:12.2022
Journal of hematology & oncology ; 15, Heft 1 (11.6.2022), 1-30, 12.2022
- Urheber
-
Kreatsoulas, Daniel
Bolyard, Chelsea
Wu, Bill X.
Cam, Hakan
Giglio, Pierre
Li, Zihai
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-022-01298-0
- URN
-
urn:nbn:de:101:1-2022080707313805778439
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kreatsoulas, Daniel
- Bolyard, Chelsea
- Wu, Bill X.
- Cam, Hakan
- Giglio, Pierre
- Li, Zihai
- SpringerLink (Online service)
Ähnliche Objekte (12)
Natural killer cell immunotherapy in glioblastoma
Current Advances in Immunotherapy for Glioblastoma
Clinical and Translational Advances in Glioma Immunotherapy
Peptide immunotherapy for childhood allergy - addressing translational challenges
CSPG4: a prototype oncoantigen for translational immunotherapy studies
Advances in immunotherapy for the treatment of glioblastoma
Current State of Immunotherapy for Treatment of Glioblastoma
Immunotherapy for glioblastoma: the promise of combination strategies
Immunocompetent murine models for the study of glioblastoma immunotherapy
MRP3: a molecular target for human glioblastoma multiforme immunotherapy
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment
Natural killer cell immunotherapy in glioblastoma
Current Advances in Immunotherapy for Glioblastoma
Clinical and Translational Advances in Glioma Immunotherapy
Peptide immunotherapy for childhood allergy - addressing translational challenges
CSPG4: a prototype oncoantigen for translational immunotherapy studies
Advances in immunotherapy for the treatment of glioblastoma
Current State of Immunotherapy for Treatment of Glioblastoma
Immunotherapy for glioblastoma: the promise of combination strategies
Immunocompetent murine models for the study of glioblastoma immunotherapy
MRP3: a molecular target for human glioblastoma multiforme immunotherapy
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment
Natural killer cell immunotherapy in glioblastoma
Current Advances in Immunotherapy for Glioblastoma
Clinical and Translational Advances in Glioma Immunotherapy
Peptide immunotherapy for childhood allergy - addressing translational challenges
CSPG4: a prototype oncoantigen for translational immunotherapy studies
Advances in immunotherapy for the treatment of glioblastoma
Current State of Immunotherapy for Treatment of Glioblastoma
Immunotherapy for glioblastoma: the promise of combination strategies
Immunocompetent murine models for the study of glioblastoma immunotherapy
MRP3: a molecular target for human glioblastoma multiforme immunotherapy
Immunotherapy for glioblastoma: current state, challenges, and future perspectives